Predicting sensitivity to CDK4/6 inhibition in ER+/HER2-breast cancer cell lines

被引：1
|
作者：
Bathurst, Lauren [1 ]
Liao, Linda [1 ]
Crozier, Cheryl [1 ]
Bayani, Jane [1 ]
Bartlett, John [1 ]
Spears, Melanie [1 ]
机构：
[1] Ontario Inst Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-PD2-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD2-10
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of CDK4/6 bifunctional degraders for ER+/HER2-breast cancer
    Majeski, Hannah
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah M.
    Liu, Qiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2-breast cancer
    Knudsen, Erik S.
    Witkiewicz, Agnieszka K.
    [J]. ONCOTARGET, 2016, 7 (43) : 69111 - 69123
  • [3] Discovery of CDK4/6 bifunctional degraders for ER+/HER2-breast cancer andtriple negative breast cancer
    Majeski, Hannah
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Liu, Qiao
    Shakya, Arvind
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [4] CDK4/6 INHIBITION IMPROVES SURVIVAL IN ER+, HER2- BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2015, 5 (02) : 107 - 107
  • [5] Molecular stratification of ER+/HER2-breast cancer cell lines to predict sensitivity to targeted agents
    Bathurst, L.
    Liao, L.
    Crozier, C.
    Lyttle, N.
    Marcellus, R.
    Bayani, J.
    Al-Awar, R.
    Bartlett, J.
    Spears, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [6] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [7] A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2-breast cancer
    Servetto, Alberto
    Napolitano, Fabiana
    Angelis, Carmine De
    Placido, Pietro De
    Giuliano, Mario
    Arpino, Grazia
    Placido, Sabino De
    Bianco, Roberto
    Formisano, Luigi
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [8] CDK4/6 for ER+
    Mayer, I. A.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [9] Subcellular MLH1 protein as first in class biomarker for CDK4/6 response in endocrine resistant ER+/HER2-breast cancer
    Mazumder, Aloran
    Oropeza, Elena
    Punturi, Nindo
    Haricharan, Svasti
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [10] Breast Cancer CDK4/6 Inhibitors in Patients with metastatic HR+/HER2-Breast Cancer
    Schmale, Ine
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (1-2)
12345